Healthcare
Ohio Senate Passes Permanent Telehealth Reform
Ohio champions telehealth reform and other states should follow their lead.
President Biden Again Calls for Price Controls
President Biden's Monday speech included the same dangerous and wrong solutions to lower drug costs.
CCAGW Urges Ohio Senate Health Committee to Support HB 122
H.B. 122 provides a permanent expansion of coverage of telehealth services, expands the list of practitioners who can provide telehealth services, and makes telehealth reforms permanent.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.
Build Back Better Act Nicotine Tax Fails to Improve Public Health and Funds Wasteful Spending
The Build Back Better Act contains a nicotine tax that negatively impacts tobacco harm reduction efforts and public health.
CCAGW Urges Michigan Legislature to Oppose HB 4348
HB 4348 would harm the ability of PBMs to use a variety of tools and policies that help clients manage their pharmacy benefits and lower drug costs.
House Votes for Biden’s Build Back Broke Bill
The BBBA is a disastrous and wasteful bill that will raise costs further for all Americans and increase government control.
Build Back Better Act Will Destroy Vibrant U.S. Pharmaceutical Industry
CAGW's latest report “Price Controls on Pharmaceuticals Are Bad Medicine,” analyzes destructive policies in the BBBA.
The Republic is Safe, For Now
Congress has been on recess for a week, so the nation is safe from more prolific spending - for now.
Congress Should Listen to Voters and Reject Drug Price Controls
A message was sent by voters in Virginia, New Jersey, and New York last night. Is Congress listening?
Price Controls Must Not Be Included in Reconciliation
The Biden administration and congressional leaders aim to implement price controls on healthcare.
Tobacco Harm Reduction Products Help Smokers Quit
It is discouraging to see governments around the world restrict access to THR products.
